8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      “MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report”

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The incidence of tongue cancer in young adults is on the rise. This trend is more pronounced in females. Although the aetiology is still unclear, there is mounting evidence that genetic syndromes can play a key role in development of oral cancers in this patient group. We report the first case of oral squamous cell carcinoma (oSCC) in a young adult with an MYH9-related disorder (MYH9-RD).

          Case presentation

          A 19-year-old female with a germline MYH9 variant (missense variant in exon 2: c.287C > T, (p.Ser96Leu)) was referred to the head and neck surgery department for investigation of a painful, thick right tongue ulcer. She was diagnosed with Epstein syndrome, an MYH9-RD, at 12 years of age. Her main phenotypic features were profound thrombocytopenia and marked renal impairment. The tongue biopsy confirmed SCC. Preoperative positron emission tomography (PET) revealed avidity in the right tongue and ipsilateral level 2A neck lymph node. With substantial preoperative multidisciplinary input, she underwent cancer ablation and microvascular free flap reconstruction. Her pathology showed a 35 mm diameter, 14 mm thick moderately differentiated SCC with perineural and lymphovascular invasion. Two out of 38 right neck nodes were positive for metastasis with extranodal extension. None of the 34 left neck nodes was involved.

          She had an uneventful recovery and was discharged home on day 6 postoperative day. On day 15 postoperative day, she had catastrophic bleeding in the neck with a respiratory arrest after a forceful cough. She required an emergency tracheostomy and returned to the theatre for haemostasis. Following a short inpatient stay, she was again discharged home and underwent adjuvant therapy consisting of external beam radiotherapy of 60Gy in 30 fractions. On clinical examination and PET at 6 months after surgery, she had no evidence of disease recurrence.

          Conclusions

          MYH9-RD can present with advanced locoregional oral cavity malignancy at an early age. The combination of profound thrombocytopenia and marked renal impairment can impact heavily on routine major head and neck cancer surgery and adjuvant treatment. This rare and challenging condition underlines the importance of early detection of cancer and multidisciplinary team input.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Comprehensive genomic characterization of head and neck squamous cell carcinomas

          The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations. We find that human papillomavirus-associated (HPV) tumors are dominated by helicase domain mutations of the oncogene PIK3CA, novel alterations involving loss of TRAF3, and amplification of the cell cycle gene E2F1. Smoking-related HNSCCs demonstrate near universal loss of TP53 mutations and CDKN2A with frequent copy number alterations including a novel amplification of 11q22. A subgroup of oral cavity tumors with favorable clinical outcomes displayed infrequent CNAs in conjunction with activating mutations of HRAS or PIK3CA, coupled with inactivating mutations of CASP8, NOTCH1 and wild-type TP53. Other distinct subgroups harbored novel loss of function alterations of the chromatin modifier NSD1, Wnt pathway genes AJUBA and FAT1, and activation of oxidative stress factor NFE2L2, mainly in laryngeal tumors. Therapeutic candidate alterations were identified in the majority of HNSCC's.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Non-muscle myosin II takes centre stage in cell adhesion and migration.

            Non-muscle myosin II (NM II) is an actin-binding protein that has actin cross-linking and contractile properties and is regulated by the phosphorylation of its light and heavy chains. The three mammalian NM II isoforms have both overlapping and unique properties. Owing to its position downstream of convergent signalling pathways, NM II is central in the control of cell adhesion, cell migration and tissue architecture. Recent insight into the role of NM II in these processes has been gained from loss-of-function and mutant approaches, methods that quantitatively measure actin and adhesion dynamics and the discovery of NM II mutations that cause monogenic diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Generation of compartmentalized pressure by a nuclear piston governs cell motility in a 3D matrix.

              Cells use actomyosin contractility to move through three-dimensional (3D) extracellular matrices. Contractility affects the type of protrusions cells use to migrate in 3D, but the mechanisms are unclear. In this work, we found that contractility generated high-pressure lobopodial protrusions in human cells migrating in a 3D matrix. In these cells, the nucleus physically divided the cytoplasm into forward and rear compartments. Actomyosin contractility with the nucleoskeleton-intermediate filament linker protein nesprin-3 pulled the nucleus forward and pressurized the front of the cell. Reducing expression of nesprin-3 decreased and equalized the intracellular pressure. Thus, the nucleus can act as a piston that physically compartmentalizes the cytoplasm and increases the hydrostatic pressure between the nucleus and the leading edge of the cell to drive lamellipodia-independent 3D cell migration.
                Bookmark

                Author and article information

                Contributors
                Takako.Yabe@health.nsw.gov.au
                Journal
                Diagn Pathol
                Diagn Pathol
                Diagnostic Pathology
                BioMed Central (London )
                1746-1596
                6 February 2022
                6 February 2022
                2022
                : 17
                : 23
                Affiliations
                [1 ]GRID grid.417154.2, ISNI 0000 0000 9781 7439, Department of Head and Neck Surgery, Wollongong Hospital, ; Wollongong, NSW Australia
                [2 ]GRID grid.510958.0, Illawarra Health and Medical Research Institute, ; Wollongong, NSW Australia
                [3 ]GRID grid.508553.e, ISNI 0000 0004 0587 927X, Illawarra Shoalhaven Local Health District, ; NSW Health Pathology South, Wollongong Hospital, Wollongong, NSW Australia
                [4 ]GRID grid.414009.8, ISNI 0000 0001 1282 788X, Kids Cancer Centre, Sydney Children’s Hospital, ; Sydney, NSW Australia
                [5 ]GRID grid.1005.4, ISNI 0000 0004 4902 0432, School of Women’s and Children’s Health, , University of New South Wales Sydney, ; Sydney, NSW Australia
                [6 ]GRID grid.413249.9, ISNI 0000 0004 0385 0051, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, ; Sydney, NSW Australia
                [7 ]GRID grid.1013.3, ISNI 0000 0004 1936 834X, Central Clinical School, , The University of Sydney, ; Sydney, NSW Australia
                [8 ]GRID grid.417154.2, ISNI 0000 0000 9781 7439, Department of Radiation Oncology, Wollongong Hospital, ; Wollongong, NSW Australia
                [9 ]GRID grid.1007.6, ISNI 0000 0004 0486 528X, Faculty of Science, Medicine and Health, , University of Wollongong, ; Wollongong, NSW Australia
                Author information
                http://orcid.org/0000-0002-4523-8595
                https://orcid.org/0000-0002-7435-0834
                https://orcid.org/0000-0003-2940-313X
                https://orcid.org/0000-0003-4547-6611
                Article
                1210
                10.1186/s13000-022-01210-x
                8818095
                35125114
                1f3ec64f-86e4-4728-b933-231b15a64994
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 14 October 2021
                : 25 January 2022
                Categories
                Case Report
                Custom metadata
                © The Author(s) 2022

                Pathology
                squamous cell carcinoma,tongue,young adult,myh9,epstein syndrome,neck dissection,free flap,microvascular surgery

                Comments

                Comment on this article